IGC Pharma, Inc. has amended its Articles of Incorporation to increase its authorized common stock from 150 million shares to 600 million shares, effective December 12, 2025, following stockholder approval on October 10, 2025. This change elevates the total authorization to 601 million shares, including 1 million preferred shares.